HRMY - Harmony inks licensing deal for sleep disorder therapy
2024-04-11 12:36:36 ET
More on Harmony Biosciences
- Harmony Biosciences Holdings, Inc. (HRMY) Q4 2023 Earnings Call Transcript
- Harmony Biosciences Non-GAAP EPS of $0.73 misses by $0.18, revenue of $168.4M in-line
- Harmony Biosciences Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Harmony Biosciences
- Historical earnings data for Harmony Biosciences